Lynda Erskine

Lynda Erskine

Auto-generated profile, based on publicly available information

Lynda Erskine

School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, UK

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2002 in Neuron
Verified
Journal Article
Closed access
APAndrew S. Plump
Andrew S. Plump
LELynda Erskine
Lynda Erskine
CSChristelle Sabatier
Christelle Sabatier
KBKatja Brose
Katja Brose
CECharles J. Epstein
Charles J. Epstein
MTMarc Tessier-Lavigne
Marc Tessier-Lavigne

1 September 2003 in Neuron
Verified
Journal Article
Closed access
SWScott E. Williams
Scott E. Williams
FMFanny Mann
Fanny Mann
LELynda Erskine
Lynda Erskine
TSTakeshi Sakurai
Takeshi Sakurai
SWShiniu Wei
Shiniu Wei
MHMark Henkemeyer
Mark Henkemeyer

1 July 2000 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
LELynda Erskine
Lynda Erskine
SWScott E. Williams
Scott E. Williams
KBKatja Brose
Katja Brose
TKThomas Kidd
Thomas Kidd
RRRivka A. Rachel
Rivka A. Rachel
CMCarol A. Mason
Carol A. Mason
The ventral midline of the nervous system is an important choice point at which growing axons decide whether to cross and project contralaterally or remain on the same side of the brain. InDrosophila, the decision to cross or avoid the CNS midline is controlled, at least in part, by the Roundabout (Robo) receptor on the axons and its ligand, Slit, an inhibitory extracellular matrix molecule secreted by the midline glia. Vertebrate homologs of these molecules have been cloned and have also been implicated in regulating axon guidance. Usingin situhybridization, we have determined the expression patterns ofrobo1,2andslit1,2,3in the mouse retina and in the region of the developing optic chiasm, a ventral midline structure in which retinal ganglion cell (RGC) axons diverge to either side of the brain. The receptors and ligands are expressed at the appropriate time and place, in both the retina and the ventral diencephalon, to be able to influence RGC axon guidance.In vitro,slit2is inhibitory to RGC axons, with outgrowth of both ipsilaterally and contralaterally projecting axons being strongly affected. Overall, these results indicate that Robos and Slits alone do not directly control RGC axon divergence at the optic chiasm and may additionally function as a general inhibitory guidance system involved in determining the relative position of the optic chiasm at the ventral midline of the developing hypothalamus.

1 November 2009 in Neuron
Verified
Journal Article
Closed access
PFPeter G. Fuerst
Peter G. Fuerst
FBFreyja Bruce
Freyja Bruce
MTMiao Tian
Miao Tian
WWWei Wei
Wei Wei
JEJustin Elstrott
Justin Elstrott
RBRobert W. Burgess
Robert W. Burgess

26 May 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CTChristina Therapontos
Christina Therapontos
LELynda Erskine
Lynda Erskine
EGErin R. Gardner
Erin R. Gardner
WFWilliam D. Figg
William D. Figg
NVNeil Vargesson
Neil Vargesson
Thalidomide is a potent teratogen that induces a range of birth defects, most commonly of the developing limbs. The mechanisms underpinning the teratogenic effects of thalidomide are unclear. Here we demonstrate that loss of immature blood vessels is the primary cause of thalidomide-induced teratogenesis and provide an explanation for its action at the cell biological level. Antiangiogenic but not antiinflammatory metabolites/analogues of thalidomide induce chick limb defects. Both in vitro and in vivo, outgrowth and remodeling of more mature blood vessels is blocked temporarily, whereas newly formed, rapidly developing, angiogenic vessels are lost. Such vessel loss occurs upstream of changes in limb morphogenesis and gene expression and, depending on the timing of drug application, results in either embryonic death or developmental defects. These results explain both the timing and relative tissue specificity of thalidomide embryopathy and have significant implications for its use as a therapeutic agent.

1 October 2014 in ASN Neuro
Verified
Journal Article
Open access
LELynda Erskine
Lynda Erskine
EHEloisa Herrera
Eloisa Herrera
The visual system is beautifully crafted to transmit information of the external world to visual processing and cognitive centers in the brain. For visual information to be relayed to the brain, a series of axon pathfinding events must take place to ensure that the axons of retinal ganglion cells, the only neuronal cell type in the retina that sends axons out of the retina, find their way out of the eye to connect with targets in the brain. In the past few decades, the power of molecular and genetic tools, including the generation of genetically manipulated mouse lines, have multiplied our knowledge about the molecular mechanisms involved in the sculpting of the visual system. Here, we review major advances in our understanding of the mechanisms controlling the differentiation of RGCs, guidance of their axons from the retina to the primary visual centers, and the refinement processes essential for the establishment of topographic maps and eye-specific axon segregation. Human disorders, such as albinism and achiasmia, that impair RGC axon growth and guidance and, thus, the establishment of a fully functioning visual system will also be discussed.